Pay in 4 interest-free payments of $6.23 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Synthesis & Quality
B-cell depletion with obinutuzumab for the treatment of proliferative lupus nephritis: a randomised, double-blind, placebo-controlled trial
Even in contemporary series, as many as 33% of surgically and over 50% of percutaneously revascularized patients are left with residual lesions post-procedurally
Ghrelin and NUCB2/nesfatin-1 are expressed in the same gastric cell and differentially correlated with body mass index in obese subjects
These vendors operate outside the legal pathway for human therapeutic use
US$ 24.01
US$ 25.22
US$ 27.18
US$ 20.04
US$ 26.58
